Safety of indacaterol, a novel once-daily β2-agonist, in persistent asthma.

被引：0
|
作者：
Yang, W.
Higgins, M.
Cameron, R.
Owen, R.
Yegen, U.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2007年 / 98卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A79 / A79
页数：1
相关论文
共 50 条
  • [31] Is once-daily Asthma Therapy effective?
    Feldmann, Christoph
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (05) : 305 - 306
  • [32] Efficacy and Safety of Indacaterol, a New 24-hour 2-Agonist, in Patients with Asthma: A Dose-Ranging Study
    Kanniess, Frank
    Boulet, Louis-Philippe
    Pierzchala, Wladyslaw
    Cameron, Ray
    Owen, Roger
    Higgins, Mark
    JOURNAL OF ASTHMA, 2008, 45 (10) : 887 - 892
  • [33] Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma
    Banov, CH
    Howland, WC
    Lumry, WR
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 86 (06) : 627 - 632
  • [34] Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
    Bateman, Eric D.
    Bleecker, Eugene R.
    Lotvall, Jan
    Woodcock, Ashley
    Forth, Richard
    Medley, Hilary
    Davis, Angela M.
    Jacques, Loretta
    Haumann, Brett
    Busse, William W.
    RESPIRATORY MEDICINE, 2012, 106 (05) : 642 - 650
  • [35] Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study
    O'Byrne, Paul M.
    D'Urzo, Tony
    Beck, Ekkehard
    Flezar, Matjaz
    Gahlemann, Martina
    Hart, Lorna
    Blahova, Zuzana
    Toorawa, Robert
    Beeh, Kai-Michael
    RESPIRATORY RESEARCH, 2015, 16
  • [36] Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma
    Buhl, R
    Creemers, JPHM
    Vondra, V
    Martelli, NA
    Naya, IP
    Ekström, A
    RESPIRATORY MEDICINE, 2003, 97 (04) : 323 - 330
  • [37] Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study
    Paul M. O’Byrne
    Tony D’Urzo
    Ekkehard Beck
    Matjaž Fležar
    Martina Gahlemann
    Lorna Hart
    Zuzana Blahova
    Robert Toorawa
    Kai-Michael Beeh
    Respiratory Research, 16
  • [38] Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study
    Vincken, Walter
    Aumann, Joseph
    Chen, Hungta
    Henley, Michelle
    McBryan, Danny
    Goyal, Pankaj
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 215 - 228
  • [39] Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids
    D'Urzo, A
    Karpel, JP
    Busse, WW
    Boulet, LP
    Monahan, ME
    Lutsky, B
    Staudinger, H
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1281 - 1289
  • [40] Turning a Molecule into a Medicine: the Development of Indacaterol as a Novel Once-Daily Bronchodilator Treatment for Patients with COPD
    Lorraine Murphy
    Stephen Rennard
    James Donohue
    Mathieu Molimard
    Ronald Dahl
    Kai-Michael Beeh
    Juergen Dederichs
    Hans-Jürgen Fülle
    Mark Higgins
    David Young
    Drugs, 2014, 74 : 1635 - 1657
12345